During the recent session, Viatris Inc. (NASDAQ:VTRS)’s traded shares were 1.32 million, with the beta value of the company hitting 1.23. At the last check today, the stock’s price was $9.61, reflecting an intraday loss of -0.05% or -$0.01. The 52-week high for the VTRS share is $15.60, that puts it down -62.33 from that peak though still a striking 1.77% gain since the share price plummeted to a 52-week low of $9.44. The company’s market capitalization is $12.12B, and the average intraday trading volume over the past 10 days was 14.72 million shares, and the average trade volume was 11.59 million shares over the past three months.
Viatris Inc. (VTRS) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.60. VTRS has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 2 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.83.
Viatris Inc. (NASDAQ:VTRS) trade information
Viatris Inc. (VTRS) registered a -0.05% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.05% in intraday trading to $9.61 this Thursday, 08/04/22, hitting a weekly high. The stock’s 5-day price performance is -1.64%, and it has moved by -6.60% in 30 days. Based on these gigs, the overall price performance for the year is -30.09%. The short interest in Viatris Inc. (NASDAQ:VTRS) is 27.47 million shares and it means that shorts have 3.04 day(s) to cover.
The consensus price target of analysts on Wall Street is $13.44, which implies an increase of 28.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $21.00 respectively. As a result, VTRS is trading at a discount of -118.52% off the target high and 6.35% off the low.
Viatris Inc. (VTRS) estimates and forecasts
Statistics show that Viatris Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Viatris Inc. (VTRS) shares have gone down -37.12% during the last six months, with a year-to-date growth rate less than the industry average at -7.84% against 0.40. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -15.30% this quarter and then drop -12.10% in the quarter after that. In the rating firms’ projections, revenue will decrease -4.40% compared to the previous financial year.
Revenue for the current quarter is expected to be $4.18 billion as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to $4.35 billion by the end of Sep 2022.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -25.70%. While earnings are projected to return 5.80% in 2022, the next five years will return -1.30% per annum.
Viatris Inc. is due to release its next quarterly earnings on November 08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Viatris Inc. is 0.48, with the dividend yield indicating at 4.99 percent, continuing the trend of increasing dividends in recent years.
Viatris Inc. (NASDAQ:VTRS)’s Major holders
Viatris Inc. insiders own 0.21% of total outstanding shares while institutional holders control 75.41%, with the float percentage being 75.57%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 1,353 institutions own stock in it. As of Mar 30, 2022, the company held over 138.36 million shares (or 11.41% of all shares), a total value of $1.51 billion in shares.
The next largest institutional holding, with 88.27 million shares, is of Blackrock Inc.’s that is approximately 7.28% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $960.38 million.
Also, the Mutual Funds coming in first place with the largest holdings of Viatris Inc. (VTRS) shares are Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund. Data provided on Apr 29, 2022 indicates that Vanguard Specialized-Health Care Fund owns about 55.23 million shares. This amounts to just over 4.56 percent of the company’s overall shares, with a $570.56 million market value. The same data shows that the other fund manager holds slightly less at 35.05 million, or about 2.89% of the stock, which is worth about $381.33 million.